iShares Neuroscience And Healthcare ETF (IBRN) closed at $29.97 on October 16, 2026, down 2.4% from the previous close, on volume of 496 shares (30-day average 1,975).
Data as of October 16, 2026.
No headlines found.
No press releases found.
No news found.
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience. Proviedes exposure to global stocks involved in the research, development and treatment of neurological disorders.
iShares Neuroscience And Healthcare ETF trades on the ARCA stock market under the symbol IBRN.
As of October 19, 2026, IBRN stock price climbed to $30.68 with 918 million shares trading.
IBRN has a market cap of $6.14 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, IBRN traded as high as $43.01 and as low as $17.86.
IBRN has underperformed the market in the last year with a price return of +7.5% while the SPY ETF gained +17.4%. IBRN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -17.9% and -5.8%, respectively, while the SPY returned +2.6% and -0.2%, respectively.
IBRN support price is $29.46 and resistance is $30.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBRN shares will trade within this expected range on the day.
